This is a preview of subscription content, log in via an institution to check access.
Notes
2017 US dollars
Reference
Kapoor R, et al. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis. Value in Health 23: 1171-1179, No. 9, Sep 2020. Available from: URL: http://doi.org/10.1016/j.jval.2020.04.1829
Rights and permissions
About this article
Cite this article
MicroRNA-based screening cost effective in diagnosing gastric cancer. PharmacoEcon Outcomes News 863, 19 (2020). https://doi.org/10.1007/s40274-020-7173-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7173-y